Patient-important outcomes reported in randomized controlled trials of pharmacologic treatments for COVID-19: A protocol of a META-epidemiological study

Background: The coronavirus disease 19 (covid-19) pandemic has underscored the need to expedite clinical research, which may lead investigators to shift away from measuring patient-important outcomes (PIO), limiting research applicability. We aim to investigate if randomized controlled trials (RCTs)...

Full description

Saved in:
Bibliographic Details
Institution:Universidad EIA
Main Authors: Jimenez‑Mora, Mario A., Ramírez-Varela, Andrea, Meneses‑Echavez, Jose F., Bidonde, Julia, Angarita‑Fonseca, Adriana, Siemieniuk, Reed A. C., Zeraatkar, Dena, Bartoszko, Jessica J., Brignardello‑Petersen, Romina, Honarmand, Kimia, Rochwerg, Bram, Guyatt, Gordon, Yepes‑Nuñez, Juan José, Fisioterapia Integral
Format: Artículo de revista
Language:English
Published: Reino Unido 2021-11-01
Subjects:
Online Access:https://repositorio.udes.edu.co/handle/001/6307
Tags: Add Tag
No Tags, Be the first to tag this record!